Search research articles
Contact Us
Filters
Showing results (161-170 of 202) with videos related to
Page
of 21
Sort By:
Endocrinology
|
September 1, 1985
Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues
I Jialal, M Crettaz, H L Hachiya, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1995
Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density
H N Rosen, V Chen, A Cittadini, et al.
Therapeutic Innovation & Regulatory Science
|
May 26, 2018
Developing, Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)
Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1981
Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C
A C Moses, M E Molitch, C T Sawin, et al.
Calcified Tissue International
|
January 1, 1994
Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover
H N Rosen, R Dresner-Pollak, A C Moses, et al.
Calcified Tissue International
|
September 1, 1994
Subregion analysis of the rat femur: a sensitive indicator of changes in bone density following treatment with thyroid hormone or bisphosphonates
H N Rosen, V L Middlebrooks, E K Sullivan, et al.
Diabetes Care
|
October 30, 2019
Redefining Hypoglycemia in Clinical Trials: Validation of Definitions Recently Adopted by the American Diabetes Association/European Association for the Study of Diabetes
Simon R Heller, John B Buse, Robert Ratner, et al.
Calcified Tissue International
|
February 1, 2000
Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy
H N Rosen, A C Moses, J Garber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1980
Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum
A C Moses, S P Nissley, P A Short, et al.
Antiviral Research
|
August 24, 2018
Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
Hsu-Feng Chu, Chiao-Che Chen, David C Moses, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 202) with videos related to
Sort By:
Page
of 21
Endocrinology
|
September 1, 1985
Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues
I Jialal, M Crettaz, H L Hachiya, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1995
Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density
H N Rosen, V Chen, A Cittadini, et al.
Therapeutic Innovation & Regulatory Science
|
May 26, 2018
Developing, Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)
Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1981
Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C
A C Moses, M E Molitch, C T Sawin, et al.
Calcified Tissue International
|
January 1, 1994
Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover
H N Rosen, R Dresner-Pollak, A C Moses, et al.
Calcified Tissue International
|
September 1, 1994
Subregion analysis of the rat femur: a sensitive indicator of changes in bone density following treatment with thyroid hormone or bisphosphonates
H N Rosen, V L Middlebrooks, E K Sullivan, et al.
Diabetes Care
|
October 30, 2019
Redefining Hypoglycemia in Clinical Trials: Validation of Definitions Recently Adopted by the American Diabetes Association/European Association for the Study of Diabetes
Simon R Heller, John B Buse, Robert Ratner, et al.
Calcified Tissue International
|
February 1, 2000
Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy
H N Rosen, A C Moses, J Garber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1980
Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum
A C Moses, S P Nissley, P A Short, et al.
Antiviral Research
|
August 24, 2018
Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine
Hsu-Feng Chu, Chiao-Che Chen, David C Moses, et al.
Page
of 21